ClinicalTrials.Veeva

Menu

Appropriate Inhaler Use of Tiotropium As Add-on Therapy in Symptomatic Asthma

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Completed

Conditions

Asthma

Treatments

Other: Correct/recheck strategy
Other: Usual verbal instruction

Study type

Interventional

Funder types

Other

Identifiers

NCT04696965
202002047B0

Details and patient eligibility

About

This pragmatic, two-arm, randomized controlled trial study aim to survey the inhaler errors of add-on tiotropium therapy with ICS+LABA in real-world practice of asthma patients and the efficacy of recheck stratage of inhaler skills. Patient characteristics and inflammatory features will be evaluated prospectively for association of asthma control by add-on tiotropium.

Full description

  1. The clinical efficacy of tiotropium as add-on treatment to ICS with a LABA have been demonstrated in clinical trials in adult patients with symptomatic asthma.
  2. Certain patients of daily care, like patients with smoking asthma, late onset asthma or asthma with chronic airway obstruction are often excluded from clinical trials.
  3. Studies have shown the cognitive function of patients with COPD is impaired. When mixed types of inhaler devices are prescribed, the multiple steps of different devices may ensure complexity and confusion for patients, which may compromise the efficacy of add-on therapy. The inhaler error of add-on tiotropium treatment in real-world asthma treatment is unknown.
  4. The improvement of step errors after varieties of teaching intervention is around 30~50%. Strategy of recheck inhaler technique recommended by the treatment guideline may optimized inhaler use. (https://ginasthma.org/gina-reports/).
  5. Factors like responseness of short-acting bronchodilators and cholinergic tone have been reported as predictors of a positive clinical response of add-on tiotropium. However, more specific physiological or inflammatory factors. e.g. exhaled nitric oxide test (FeNo), and para symptomatic function and cardiac-pulmonary interaction have not been evaluated prospectively.
  6. This pragmatic, two-arm, randomized controlled trial study aim to survey the inhaler errors of add-on tiotropium therapy with ICS+LABA in real-world practice of asthma patients and the efficacy of recheck stratage of inhaler skills. Patient characteristics and inflammatory features will be evaluated prospectively for association of asthma control by add-on tiotropium.

Enrollment

48 patients

Sex

All

Ages

20 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 20 to 75 years old asthmatic patients under regular treatment
  2. Received medium to high dose ICS with LABA at least 3 months
  3. Persistent asthma related symptoms: asthma control questionnaire (ACQ-7>1.5)
  4. Physicians in charged prescribed Tiotropium as add-on therapy according to clinical judgement.

Exclusion criteria

  1. Refuse to provide inform consent
  2. Pregnancy or breastfeeding women
  3. Patients with chronic obstructive pulmonary disease
  4. Using other Long-acting Muscarinic Antagonists e.g. Sebree, Ultibro, Anoro and Spiolto

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Parallel Assignment

Masking

Single Blind

48 participants in 2 patient groups

Correct/recheck strategy
Experimental group
Description:
Patients of study arm will be asked to show how they use their two inhalers and identify errors using a device-specific checklist by research assistant. Research assistant then show the patient how to use these devices correctly and give the checklist including the steps patients did wrong. After teaching by the research assistant, patients were asked to demonstrate the correct way of wrong step(s) they made at beginning.
Treatment:
Other: Correct/recheck strategy
Usual verbal instruction
Active Comparator group
Description:
Patients of control arm will be asked to show how thy use their two inhalers and identify errors using specific check list by research assistant. The educational nurse will give verbal instruction.
Treatment:
Other: Usual verbal instruction

Trial contacts and locations

1

Loading...

Central trial contact

Ting-Yu Lin; Shu-Min Lin

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems